Volume | 15 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Ehave Inc (CE) | EHVVF | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.0017 | 0.0017 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
1 | 15 | - | 0.000001 - 0.0038 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
11:14:41 | 15 | US$ 0.0001 | USD |
Ehave Inc (CE) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 611.27k | 359.57M | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Ehave (CE) News
Date | Time | Source | News Article |
---|---|---|---|
5/21/2024 | 15:10 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
10/12/2023 | 10:00 | Edgar (US Regulatory) | Form SEC STAFF ACTION - SEC Staff Action: ORDER |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EHVVF Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.001 | 0.0017 | 0.0001 | 0.0016478 | 319,093 | 0.0007 | 70.00% |
1 Month | 0.001 | 0.0017 | 0.000001 | 0.0012807 | 245,473 | 0.0007 | 70.00% |
3 Months | 0.001 | 0.002 | 0.000001 | 0.0011262 | 298,308 | 0.0007 | 70.00% |
6 Months | 0.000001 | 0.0038 | 0.000001 | 0.0010916 | 228,061 | 0.0017 | 169,900.00% |
1 Year | 0.0029 | 0.0038 | 0.000001 | 0.0013673 | 169,410 | -0.0012 | -41.38% |
3 Years | 0.069 | 0.10 | 0.000001 | 0.0178207 | 740,004 | -0.0673 | -97.54% |
5 Years | 0.05 | 1.10 | 0.000001 | 0.0590865 | 713,788 | -0.0483 | -96.60% |
Ehave (CE) Description
Ehave, Inc. (EHVVF) is a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes. Our main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insights. The Ehave Infinity Portal offers a powerful machine learning and artificial intelligence platform with a growing set of advanced tools and applications developed by Ehave and its leading partners. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools. Additional information on Ehave can be found on the Company's website at: www.ehave.com. |